An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3'-UTR interactions in breast cancer cells

Nucleic Acids Research

Volumn 42, Issue 5, 2014, Pages 3073-3088

  Su, Chia Hsin ^a   Tzeng, Tsai Yu ^a   Cheng, Ching ^a   Hsu, Ming Ta ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Chien Tien Hsu Cancer Research Foundation   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MYC PROTEIN; PROTEIN BCL 2;

3' UNTRANSLATED REGION; ARTICLE; BCL2 GENE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CMYC GENE; CONTROLLED STUDY; DNA HISTONE INTERACTION; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; H2AC GENE; HUMAN; HUMAN TISSUE; LSD1 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CHROMATIN; ENHANCER ELEMENTS, GENETIC; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, MYC; HISTONES; HUMANS; MCF-7 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION, GENETIC;

EID: 84898960295     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1341     Document Type: Article

References (45)

1. Kornberg, R.D. (1974) Chromatin structure: A repeating unit of histones and DNA. Science, 184, 868-871.
2. Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F. and Richmond, T.J. (1997) Crystal structure of the nucleosome core particle at 2.8 a resolution. Nature, 389, 251-260. (Pubitemid 27406632
3. Hizume, K., Yoshimura, S.H. and Takeyasu, K. (2005) Linker histone H1 per se can induce three-dimensional folding of chromatin fiber. Biochemistry, 44, 12978-12989. (Pubitemid 41377278
4. Bhaumik, S.R., Smith, E. and Shilatifard, A. (2007) Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol., 14, 1008-1016.
5. De, K.L., Corpet, A., Haber, J.E. and Almouzni, G. (2007) Histone chaperones: An escort network regulating histone traffic. Nat. Struct. Mol. Biol., 14, 997-1007.
6. Latham, J.A. and Dent, S.Y. (2007) Cross-regulation of histone modifications. Nat. Struct. Mol. Biol., 14, 1017-1024.
7. Billon, P. and Cote, J. (2012) Precise deposition of histone H2A.Z in chromatin for genome expression and maintenance. Biochim. Biophys. Acta, 1819, 290-302.
8. Chadwick, B.P. and Willard, H.F. (2001) A novel chromatin protein, distantly related to histone H2A, is largely excluded from the inactive X chromosome. J. Cell Biol., 152, 375-384. (Pubitemid 34285606
9. Costanzi, C. and Pehrson, J.R. (1998) Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature, 393, 599-601. (Pubitemid 28319252
10. Sancho, M., Diani, E., Beato, M. and Jordan, A. (2008) Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth. PLoS Genet., 4, e1000227.
11. Gevry, N., Hardy, S., Jacques, P.E., Laflamme, L., Svotelis, A., Robert, F. and Gaudreau, L. (2009) Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev., 23, 1522-1533.
12. Marzluff, W.F., Gongidi, P., Woods, K.R., Jin, J. and Maltais, L.J. (2002) The human and mouse replication-dependent histone genes. Genomics, 80, 487-498. (Pubitemid 35333791
13. Shann, Y.J., Cheng, C., Chiao, C.H., Chen, D.T., Li, P.H. and Hsu, M.T. (2008) Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res., 18, 791-801. (Pubitemid 351645069
14. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A. et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med., 14, 518-527.
15. Alimonti, A., Carracedo, A., Clohessy, J.G., Trotman, L.C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W.J., Brogi, E. et al. (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat. Genet., 42, 454-458.
16. Dekker, J., Rippe, K., Dekker, M. and Kleckner, N. (2002) Capturing chromosome conformation. Science, 295, 1306-1311. (Pubitemid 34157624
17. Wang, Q., Carroll, J.S. and Brown, M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell, 19, 631-642.
18. Lin, C.Y., Vega, V.B., Thomsen, J.S., Zhang, T., Kong, S.L., Xie, M., Chiu, K.P., Lipovich, L., Barnett, D.H., Stossi, F. et al. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet., 3, e87.
19. Carroll, J.S., Meyer, C.A., Song, J., Li, W., Geistlinger, T.R., Eeckhoute, J., Brodsky, A.S., Keeton, E.K., Fertuck, K.C., Hall, G.F. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289-1297.
20. Svotelis, A., Bianco, S., Madore, J., Huppe, G., Nordell-Markovits, A., Mes-Masson, A.M. and Gevry, N. (2011) H3K27 demethylation by JMJD3 at a poised enhancer of anti-Apoptotic gene BCL2 determines ERalpha ligand dependency. EMBO J., 30, 3947-3961.
21. Kim, M.Y., Hsiao, S.J. and Kraus, W.L. (2001) A role for coactivators and histone acetylation in estrogen receptor alphamediated transcription initiation. EMBO J., 20, 6084-6094. (Pubitemid 33049283
22. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A. and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103, 843-852.
23. Berry, N.B., Fan, M. and Nephew, K.P. (2008) Estrogen receptor-Alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome. Mol. Endocrinol., 22, 1535-1551.
24. Stenoien, D.L., Patel, K., Mancini, M.G., Dutertre, M., Smith, C.L., O'Malley, B.W. and Mancini, M.A. (2001) FRAP reveals that mobility of oestrogen receptor-Alpha is ligand-And proteasomedependent. Nat. Cell Biol., 3, 15-23.
25. Zheng, S., Wyrick, J.J. and Reese, J.C. (2010) Novel trans-Tail regulation of H2B ubiquitylation and H3K4 methylation by the N terminus of histone H2A. Mol. Cell Biol., 30, 3635-3645.
26. Perillo, B., Ombra, M.N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, C. and Avvedimento, E.V. (2008) DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science, 319, 202-206.
27. Wang, J., Hevi, S., Kurash, J.K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G. et al. (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet., 41, 125-129.
28. Wissmann, M., Yin, N., Muller, J.M., Greschik, H., Fodor, B.D., Jenuwein, T., Vogler, C., Schneider, R., Gunther, T., Buettner, R. et al. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol., 9, 347-353.
29. Perissi, V. and Rosenfeld, M.G. (2005) Controlling nuclear receptors: The circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol., 6, 542-554.
30. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M. and Gannon, F. (2003) Estrogen receptor-Alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763. (Pubitemid 38030303
31. Svotelis, A., Gevry, N., Grondin, G. and Gaudreau, L. (2010) H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle, 9, 364-370.
32. Welboren, W.J., van Driel, M.A., Janssen-Megens, E.M., van Heeringen, S.J., Sweep, F.C., Span, P.N. and Stunnenberg, H.G. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J., 28, 1418-1428.
33. Barnett, D.H., Sheng, S., Charn, T.H., Waheed, A., Sly, W.S., Lin, C.Y., Liu, E.T. and Katzenellenbogen, B.S. (2008) Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res., 68, 3505-3515.
34. Deschenes, J., Bourdeau, V., White, J.H. and Mader, S. (2007) Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J. Biol. Chem., 282, 17335-17339.
35. Fullwood, M.J., Liu, M.H., Pan, Y.F., Liu, J., Xu, H., Mohamed, Y.B., Orlov, Y.L., Velkov, S., Ho, A., Mei, P.H. et al. (2009) An oestrogen-receptor- Alpha-bound human chromatin interactome. Nature, 462, 58-64.
36. Fan, M., Bigsby, R.M. and Nephew, K.P. (2003) The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-Alpha and essential for the antiproliferative activity of ICI 182, 780 in ERalpha-positive breast cancer cells. Mol. Endocrinol., 17, 356-365. (Pubitemid 36315630
37. Wen, B., Wu, H., Shinkai, Y., Irizarry, R.A. and Feinberg, A.P. (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet., 41, 246-250.
38. Subramanian, V., Mazumder, A., Surface, L.E., Butty, V.L., Fields, P.A., Alwan, A., Torrey, L., Thai, K.K., Levine, S.S., Bathe, M. et al. (2013) H2A.Z acidic patch couples chromatin dynamics to regulation of gene expression programs during ESC differentiation. PLoS Genet., 9, e1003725.
39. Luk, E., Ranjan, A., Fitzgerald, P.C., Mizuguchi, G., Huang, Y., Wei, D. and Wu, C. (2010) Stepwise histone replacement by SWR1 requires dual activation with histone H2A.Z and canonical nucleosome. Cell, 143, 725-736.
40. Singh, R., Mortazavi, A., Telu, K.H., Nagarajan, P., Lucas, D.M., Thomas-Ahner, J.M., Clinton, S.K., Byrd, J.C., Freitas, M.A. and Parthun, M.R. (2013) Increasing the complexity of chromatin: Functionally distinct roles for replication-dependent histone H2A isoforms in cell proliferation and carcinogenesis. Nucleic Acids Res., 41, 9284-9295.
41. Stepanenko, A.A., Vassetzky, Y.S. and Kavsan, V.M. (2013) Antagonistic functional duality of cancer genes. Gene, 529, 199-207.
42. de Caestecker, M.P., Piek, E. and Roberts, A.B. (2000) Role of transforming growth factor-beta signaling in cancer. J. Natl Cancer Inst., 92, 1388-1402.
43. Bae, D.S., Blazanin, N., Licata, M., Lee, J. and Glick, A.B. (2009) Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Mol. Carcinog., 48, 441-453.
44. Kim, S.G. and Song, J.Y. (2012) Therapeutic targeting of oncogenic transforming growth factor-beta1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Oncol. Rep., 28, 539-544.
45. Zhu, H., Wu, K., Yan, W., Hu, L., Yuan, J., Dong, Y., Li, Y., Jing, K., Yang, Y. and Guo, M. (2013) Epigenetic silencing of DACH1 induces loss of transforming growth factor-beta1 antiproliferative response in human hepatocellular carcinoma. Hepatology, 58, 2012-2022.